Dupilumab treatment ameliorates clinical and hematological symptoms, including blood eosinophilia, in patients with atopic dermatitis.

Teruo YamauchiShun SasakiEun Seon LeeTakayuki TamuraMarina SekiTasuku MiwaKae KobayashiYusuke SarutaYuki KitamiHirohiko SuekiHideaki Watanabe

Published in: International journal of dermatology (2020)

Several studies have reported that serum TARC, LDH, and total IgE levels are reduced by dupilumab treatment. Our real-world data are the first to demonstrate a reduction in blood eosinophilia in patients who receive clinical treatment with dupilumab.

Keyphrases

atopic dermatitis
machine learning
electronic health record
depressive symptoms
big data
artificial intelligence
sleep quality